NTNU – Norwegian University of Science and Technology

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

4,341 to 4,350 of 8,623 Results

WM_measures.mat Jul 5, 2023 - Data for ‘The interplay of computational complexity and memory load during quantifier verification’ MATLAB Data - 889 B - MD5: 22a3159a0f6f05fa3dbdb3624506c4cb
NTNU Intranasal Naloxone Trial (NINA-1) Study documents Jan 22, 2021 Skulberg, Arne Kristian; Dale, Ola, 2020, "NTNU Intranasal Naloxone Trial (NINA-1) Study documents", https://doi.org/10.18710/ABRUWW, DataverseNO, V2 This section contains study documents forming the basis of the NINA-1 Trial. Documents will be added at Sponsors discretion, and aim to reflect the Trial Master File. Please consult the file 00readme for a key to how documents are coded in this dataset. If you have any specific document you would like access to, please contact us, and Sponsor will...
00readme-1.txt Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Plain Text - 3.4 KB - MD5: 1fd357a16e2d007e86ea902670754e0f Consult this document for easier access to specific documents
01_1_NINA-1_Study_protocol-version_3_3.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.9 MB - MD5: 047a45a69d3a9888429be9fc31d424dd
01_2_NINA-1_Study_protocol-version_1.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 2.6 MB - MD5: ffc0da781af143a83ebb44c6676d2993 This first trial protocol was not approved by Norwegian Medicines Agency. No participants included in the trial under this protocol
01_2_NINA-1_Study_protocol-version_2.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 3.7 MB - MD5: da81088a710c80d9917ef3129515966d This protocol version was valid prior to the inclusion of the first patient. No participants included in the trial under this protocol
01_2_NINA-1_Study_protocol-version_3_0.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 3.5 MB - MD5: 5a87c835c114353cbd447690ea466125
01_2_NINA-1_Study_protocol-version_3_1.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 5.3 MB - MD5: c32b61b404e56e7794775cfdf10d8bd4
01_2_NINA-1_Study_protocol-version_3_2.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.7 MB - MD5: b50af244dc9512517fc6573fc002f4f5
01_3_NINA-1_SPIRIT2013_33_item_checklist.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 100.2 KB - MD5: 5225602d1b3fdff2f18a9189a37b8db6 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013) This statement provides evidence for the minimum content of the NINA-1 trial protocol as outlined by SPIRIT

WM_measures.mat

Jul 5, 2023 - Data for ‘The interplay of computational complexity and memory load during quantifier verification’

MATLAB Data - 889 B -

NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Jan 22, 2021

Skulberg, Arne Kristian; Dale, Ola, 2020, "NTNU Intranasal Naloxone Trial (NINA-1) Study documents", https://doi.org/10.18710/ABRUWW, DataverseNO, V2

This section contains study documents forming the basis of the NINA-1 Trial. Documents will be added at Sponsors discretion, and aim to reflect the Trial Master File. Please consult the file 00readme for a key to how documents are coded in this dataset. If you have any specific document you would like access to, please contact us, and Sponsor will...

00readme-1.txt

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Plain Text - 3.4 KB -

Consult this document for easier access to specific documents

01_1_NINA-1_Study_protocol-version_3_3.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.9 MB -

01_2_NINA-1_Study_protocol-version_1.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 2.6 MB -

This first trial protocol was not approved by Norwegian Medicines Agency. No participants included in the trial under this protocol

01_2_NINA-1_Study_protocol-version_2.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 3.7 MB -

This protocol version was valid prior to the inclusion of the first patient. No participants included in the trial under this protocol

01_2_NINA-1_Study_protocol-version_3_0.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 3.5 MB -

01_2_NINA-1_Study_protocol-version_3_1.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 5.3 MB -

01_2_NINA-1_Study_protocol-version_3_2.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.7 MB -

01_3_NINA-1_SPIRIT2013_33_item_checklist.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 100.2 KB -

Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013) This statement provides evidence for the minimum content of the NINA-1 trial protocol as outlined by SPIRIT

Add Data

Share Dataverse

Link Dataverse

Reset Modifications